We are live on ! Find out more
PACB icon

Pacific Biosciences

71 hedge funds and large institutions have $74.4M invested in Pacific Biosciences in 2013 Q2 according to their latest regulatory filings, with 71 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more call options, than puts

Call options by funds: $50K | Put options by funds: $15K

Holders
71
Holders Change
+71
Holders Change %
% of All Funds
2.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
71
Increased
Reduced
Closed
Calls
$50K
Puts
$15K
Net Calls
+$35K
Net Calls Change
+$35K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$72K +$71K +28,522 New
Two Sigma Investments
52
Two Sigma Investments
New York
$68K +$67K +26,900 New
AIG
53
American International Group
New York
$64.3K +$63.6K +25,534 New
Ameriprise
54
Ameriprise
Minnesota
$61K +$60.2K +24,182 New
Principal Financial Group
55
Principal Financial Group
Iowa
$52K +$51.1K +20,519 New
Citigroup
56
Citigroup
New York
$50K +$49.5K +19,867 New
NI
57
Numeric Investors
Massachusetts
$46K +$45.3K +18,200 New
Morgan Stanley
58
Morgan Stanley
New York
$42K +$40.9K +16,414 New
DTL
59
Dynamic Technology Lab
Singapore
$31K +$30.9K +12,404 New
HK
60
Horizon Kinetics
New York
$30K +$29.9K +12,000 New
JP Morgan Chase
61
JP Morgan Chase
New York
$28K +$27K +10,853 New
KCG
62
Knight Capital Group
$27K +$26.3K +10,576 New
Bank of America
63
Bank of America
North Carolina
$25K +$24.6K +9,881 New
Group One Trading
64
Group One Trading
Illinois
$19K +$18.5K +7,434 New
WA
65
WFG Advisors
Texas
$19K +$19.2K +7,700 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$5K +$4.98K +2,000 New
TRCT
67
Tower Research Capital (TRC)
New York
$5K +$4.98K +2,000 New
U
68
UBS
Switzerland
$2K +$1.99K +800 New
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K +$2.39K +960 New
CA
70
CapWealth Advisors
Tennessee
$1K +$1.25K +500 New
Creative Planning
71
Creative Planning
Kansas
+$249 +100 New

PACB Hedge Fund Activity: Q2 2013 in Review

71 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q2 2013, worth a combined $74.4M.

Buyers outnumbered sellers: 71 funds opened new PACB positions and 0 closed out — a net gain of 71 holders — while 0 added to existing stakes and 0 trimmed.

  • 71 institutional investors held Pacific Biosciences (PACB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $74.4M of Pacific Biosciences stock for Q2 2013.
  • 71 funds opened new Pacific Biosciences positions in Q2 2013 and 0 closed out, a net change of +71 holders.

Based on aggregated 13F filings for Q2 2013.